Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 -0.63%85 EV-to-OCF is 18.31 as of Jul. 17, 2026, which is 34% below its 10-year median of 27.88. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 686 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 76.38% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Hospital Mater Dei's Enterprise Value is R$3,170 Mil.
Hospital Mater Dei's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was R$173 Mil. Therefore, Hospital Mater Dei's EV-to-OCF for today is 18.31.
The historical rank and industry rank for Hospital Mater Dei's EV-to-OCF or its related term are showing as below:
BSP:MATD3'
s EV-to-OCF Range Over the Past 10 Years
Min: 14.9 Med: 27.88 Max: 475.26
Current: 18.45
During the past 9 years, the highest EV-to-OCF of Hospital Mater Dei was 475.26. The lowest was 14.90. And the median was 27.88.
BSP:MATD3's EV-to-OCF is ranked worse than 76.38% of 686
companies
in the Healthcare Providers & Services industry
Industry Median: 8.715
vs BSP:MATD3: 18.45
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hospital Mater Dei (BSP:MATD3) EV-to-OCF Explanation
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hospital Mater Dei's PE Ratio (TTM) for today is calculated as:
Hospital Mater Dei's share price for today is R$4.77.
Hospital Mater Dei's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$0.372.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hospital Mater Dei EV-to-OCF Related Terms
Hospital Mater Dei EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital Mater Dei's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's EV-to-OCF falls into.
Hospital Mater Dei's current Enterprise Value is R$3,170 Mil.
Hospital Mater Dei's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was R$173 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a EV-to-OCF of 18.31 as of Jul. 17, 2026. This is 34% below median its historical median of 27.88. Over the past decade, Hospital Mater Dei's EV-to-OCF has ranged from 14.90 to 475.26. According to the industry distribution chart, Hospital Mater Dei ranks #524 out of 686 companies in the Healthcare Providers & Services industry, placing it in the top 76.4%.
Is Hospital Mater Dei's EV-to-OCF too high?
Hospital Mater Dei's current EV-to-OCF of 18.31 is 34% below median its 10-year median of 27.88. Over the past 10 years, this metric has ranged from a low of 14.90 to a high of 475.26. The Healthcare Providers & Services industry median EV-to-OCF is 8.72. Hospital Mater Dei's value of 18.31 is 110.1% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #524 out of 686 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's EV-to-OCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #524 out of 686 companies for EV-to-OCF. This places Hospital Mater Dei in the lower half of its industry. The industry median EV-to-OCF is 8.72. Hospital Mater Dei's value of 18.31 is 110.1% above this benchmark. Historically, Hospital Mater Dei's own EV-to-OCF has ranged from 14.90 to 475.26 over the past decade. While the company's 10-year median is 27.88 vs. the industry median of 8.72, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.72, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current EV-to-OCF of 18.31 is 110.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current EV-to-OCF is 18.31, which is 34% below median its own 10-year median of 27.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.89, compared to a current price of R$4.77 — trading 19% below its estimated fair value. The current EV-to-OCF is 18.31, which is 34% below median its 10-year median of 27.88 and 110.1% above the Healthcare Providers & Services industry median of 8.72. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current EV-to-OCF is 18.31 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.77 is trading 19% below its estimated GF Value™ of R$5.89.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
EV-to-OCF: 18.31 (34% below median its 10-year median of 27.88)
GF Value™: R$5.89 vs. price of R$4.77 (19% below fair value)
Industry Position: 110.1% above the Healthcare Providers & Services median (#524 of 686)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
